Hosted on MSN2mon
FDA beats EMA to most approved new drugs in 2024The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024. On 15 January, the two agencies ...
The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...
Specialised drug development company ... of the European Medicines Agency (EMA) recommending marketing authorization of Selincro (nalmefene) for the reduction of alcohol consumption in adult ...
Gilead Sciences, Inc. announced that the European Medicines Agency (EMA) has validated ... FDA’s acceptance of our New Drug Applications for lenacapavir for PrEP underscores the great interest in how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results